Progressive arterial occlusive disease (PAOD) and pulmonary arterial hypertension (PAH) as new adverse events of second generation TKIs in CML treatment: Who's afraid of the big bad wolf?

被引：9

作者：

Breccia, Massimo ^{[1
]}

Efficace, Fabio ^{[2
,3
]}

Alimena, Giuliana ^{[1
]}

机构：

[1] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, I-00161 Rome, Italy

[2] Italian Grp Adult Hematol Dis GIMEMA, Ctr Data, Rome, Italy

[3] Hlth Outcomes Res Unit, Rome, Italy

来源：

LEUKEMIA RESEARCH | 2012年 / 36卷 / 07期

关键词：

PAOD; PAH; Nilotinib; Dasatinib; CML; DASATINIB TREATMENT; IMATINIB;

D O I：

10.1016/j.leukres.2012.03.010

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：813 / 814

页数：2

共 14 条

[1] Current therapeutics and practical management strategies for pulmonary arterial hypertension [J].

Agarwal, Richa ;

Gomberg-Maitland, Mardi .

AMERICAN HEART JOURNAL, 2011, 162 (02) :201-213

[2] Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in CML [J].

Aichberger, Karl J. ;

Herndlhofer, Susanne ;

Schernthaner, Gerit-Holger ;

Schillinger, Martin ;

Mitterbauer-Hohendanner, Gerlinde ;

Sillaber, Christian ;

Valent, Peter .

AMERICAN JOURNAL OF HEMATOLOGY, 2011, 86 (07) :533-539

[3] Fully reversible pulmonary arterial hypertension associated with dasatinib treatment for chronic myeloid leukaemia [J].

Dumitrescu, D. ;

Seck, C. ;

ten Freyhaus, H. ;

Gerhardt, F. ;

Erdmann, E. ;

Rosenkranz, S. .

EUROPEAN RESPIRATORY JOURNAL, 2011, 38 (01) :218-220

[4]

EMEA, 2011, EMEA SPRYC SCI DISC

[5]

Hadzijusufovic E, 2011, BLOOD, V118

[6]

Hennigs JK, 2011, BMC PULM MED, V23, P11

[7] Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION) [J].

Kantarjian, Hagop M. ;

Shah, Neil P. ;

Cortes, Jorge E. ;

Baccarani, Michele ;

Agarwal, Mohan B. ;

Soledad Undurraga, Maria ;

Wang, Jianxiang ;

Kassack Ipina, Juan Julio ;

Kim, Dong-Wook ;

Ogura, Michinori ;

Pavlovsky, Carolina ;

Junghanss, Christian ;

Milone, Jorge H. ;

Nicolini, Franck E. ;

Robak, Tadeusz ;

Van Droogenbroeck, Jan ;

Vellenga, Edo ;

Bradley-Garelik, M. Brigid ;

Zhu, Chao ;

Hochhaus, Andreas .

BLOOD, 2012, 119 (05) :1123-1129

[8] Severe Peripheral Arterial Disease During Nilotinib Therapy [J].

Le Coutre, Philipp ;

Rea, Delphine ;

Abruzzese, Elisabetta ;

Dombret, Herve ;

Trawinska, Malgorzata M. ;

Herndlhofer, Susanne ;

Doerken, Bernd ;

Valent, Peter .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (17) :1347-1348

[9] Reversible dasatinib-induced pulmonary arterial hypertension and right ventricle failure in a previously allografted CML patient [J].

Mattei, D. ;

Feola, M. ;

Orzan, F. ;

Mordini, N. ;

Rapezzi, D. ;

Gallamini, A. .

BONE MARROW TRANSPLANTATION, 2009, 43 (12) :967-968

[10]

O'Dwyer ME, 2011, BLOOD, V118, P1612

← 1 2 →